GO:1904934 negative regulation of cell proliferation in midbrain: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904934 describes any process that stops, prevents, or reduces the frequency, rate, or extent of cell proliferation specifically in the midbrain.
• Midbrain cell proliferation is tightly controlled during development, and its dysregulation is linked to malformations and neurodevelopmental disorders [2, 5].
• Key regulatory genes include Ezh2, Wnt1, Gpr161, and catecholaminergic signaling components that modulate proliferation in the midbrain [6, 8, 4].
• Experimental models such as conditional knockout mice and zebrafish have revealed midbrain-specific proliferation defects [6, 7, 8].
• Studying this process requires methods like transcriptomics, cell cycle analysis, and lineage tracing to capture spatial and temporal dynamics [3, 5].
• CRISPR-based editing enables precise interrogation of genes controlling midbrain proliferation for disease modeling and therapeutic target discovery.
Description
The midbrain is a critical region of the central nervous system that coordinates sensory and motor functions, and its proper development depends on precise control of cell proliferation. GO:1904934, negative regulation of cell proliferation in midbrain, refers to any process that stops, prevents, or reduces the frequency, rate, or extent of cell proliferation within the midbrain. This regulation is essential for balancing progenitor expansion and differentiation during embryogenesis, and its disruption can lead to structural malformations and neurodevelopmental abnormalities [6, 8]. Researchers study this term to understand how signaling pathways and epigenetic regulators converge to shape midbrain size and cellular composition [6, 4]. Insights into GO:1904934 also inform regenerative strategies and disease modeling, as uncontrolled proliferation or premature cell cycle exit can contribute to pathology [5, 7].
negative regulation of cell proliferation in midbrain At A Glance
| GO ID | GO:1904934 |
|---|---|
| GO term | negative regulation of cell proliferation in midbrain |
| Ontology | biological_process |
| Synonym | inhibition of cell proliferation in midbrain; down-regulation of cell proliferation in mesencephalon; negative regulation of mesencepahalic cell proliferation |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of cell proliferation in the midbrain. |
| Related process | Cell cycle regulation, neurogenesis, midbrain development |
| Taxonomic scope | Eukaryotes, particularly vertebrates |
| Cellular context | Midbrain neural progenitors and surrounding niche |
What Is GO:1904934?
GO:1904934 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of cell proliferation in the midbrain. It encompasses molecular events that inhibit cell division specifically within midbrain tissue, distinguishing it from general negative regulation of cell proliferation.
Why Is negative regulation of cell proliferation in midbrain Important in Cell Biology?
GO:1904934 is important because precise control of midbrain cell proliferation is required for normal brain architecture and function. Dysregulation of this process can cause midbrain malformations, craniofacial defects, and neurodevelopmental disorders [6, 8]. Understanding the negative regulators of midbrain proliferation provides mechanistic insights into how the brain sizes itself and how perturbations lead to disease [5, 7].
• Maintains proper midbrain size and shape during development.
• Prevents excessive progenitor expansion that could lead to malformations.
• Coordinates timing of neurogenesis and differentiation.
• Involved in midbrain dopaminergic neuron development, relevant to Parkinson's disease research.
• Dysregulation linked to embryonic midbrain malformation and craniofacial defects.
• Target of environmental toxicants that affect neurodevelopment.
• Provides a model for studying region-specific cell cycle control.
• Informs regenerative medicine approaches for midbrain-related disorders.
• Helps identify therapeutic targets for neurodevelopmental disorders.
• Essential for understanding how epigenetic regulators like Ezh2 shape brain regional identity.
What Happens During negative regulation of cell proliferation in midbrain?
Initiation of negative regulation
In simple terms: The process begins when signals tell midbrain cells to slow down or stop dividing.
Negative regulation of midbrain cell proliferation is initiated by extracellular cues and intracellular signals that converge on cell cycle machinery. For example, norepinephrine acts as a negative regulator of the adult periventricular neural stem cell niche, reducing proliferation. Similarly, catecholaminergic innervation of periventricular neurogenic regions in the developing mouse brain modulates proliferative activity. These signals set the stage for region-specific control of cell division.
Epigenetic and transcriptional control
In simple terms: Master switches inside the cell change which genes are active to put the brakes on proliferation.
Epigenetic regulators such as Ezh2 are critical for maintaining midbrain identity and controlling proliferation. Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation, highlighting how chromatin modifiers enforce negative regulation of proliferation in the midbrain. Transcriptional programs downstream of Wnt signaling also contribute to this control.
Signaling pathways that inhibit proliferation
In simple terms: Specific communication lines between cells deliver stop signals for growth.
Wnt1 lineage-specific deletion of Gpr161 results in embryonic midbrain malformation and failure of craniofacial skeletal development, indicating that Gpr161-mediated signaling is required for proper negative regulation of midbrain proliferation. Additionally, temporal and spatial transcriptomic dynamics across brain development reveal waves of gene expression that restrict proliferation in a region-specific manner.
Cell cycle exit and differentiation
In simple terms: Cells permanently leave the division cycle and become specialized midbrain cells.
Negative regulation culminates in cell cycle exit and differentiation. Changes in cell cycle parameters and cell number in the rat midbrain during organogenesis show that proliferation declines as development proceeds, coinciding with differentiation. This transition is essential for generating the correct number of midbrain neurons and glia.
Integration with environmental cues
In simple terms: Outside factors like toxins can interfere with the stop signals, causing too much growth.
Environmental toxicants can disrupt negative regulation. Isoliquiritigenin induces neurodevelopmental toxicity and anxiety-like behavior in zebrafish larvae, likely by altering proliferation control in the midbrain. This underscores the importance of understanding how external factors modulate GO:1904934.
Key Genes Involved in GO:1904934 negative regulation of cell proliferation in midbrain
The following genes and proteins have been experimentally implicated in the negative regulation of cell proliferation in the midbrain.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Ezh2 | Epigenetic repressor; maintains midbrain identity and restricts proliferation | Loss causes midbrain-to-forebrain switch and deregulated proliferation |
| Wnt1 | Secreted signaling molecule; regulates midbrain development | Lineage-specific deletion affects midbrain malformation |
| Gpr161 | G-protein coupled receptor; modulates Wnt signaling | Deletion in Wnt1 lineage causes midbrain malformation |
| Norepinephrine | Neurotransmitter; negative regulator of neural stem cell proliferation | Inhibits periventricular stem cell proliferation |
| Catecholamines | Neurotransmitters; influence neurogenic niches | Innervate periventricular regions and modulate proliferation |
| Cell cycle genes (e.g., cyclins, CDKs) | Core cell cycle machinery | Parameters change during midbrain organogenesis |
| Isoliquiritigenin (compound) | Toxicant; alters neurodevelopment | Induces neurodevelopmental toxicity in zebrafish |
| Xenopus developmental genes | Temporal-spatial transcriptomic dynamics | Provide insights into brain development |
| Midbrain progenitor markers | Identify proliferating cells | Used in cell cycle analysis |
| Differentiation markers | Indicate cell cycle exit | Correlate with negative regulation |
| Apoptosis regulators | May contribute to cell number control | Potential crosstalk with proliferation |
| Wnt signaling components | Pathway that can inhibit proliferation | Implicated in midbrain malformation |
| Chromatin modifiers | Regulate gene expression | Ezh2 as example |
| Neurotransmitter receptors | Mediate niche signals | Catecholaminergic innervation |
| Toxicant-responsive genes | Mediate environmental effects | Isoliquiritigenin response |
| Stem cell niche factors | Maintain quiescence | Norepinephrine as negative regulator |
How Is negative regulation of cell proliferation in midbrain Regulated?
Negative regulation of cell proliferation in the midbrain is controlled by a combination of epigenetic, transcriptional, and signaling mechanisms. Ezh2 represses genes that promote forebrain identity, thereby maintaining midbrain proliferation arrest. Wnt signaling, through Gpr161, is essential for proper midbrain development and craniofacial skeletal formation. Norepinephrine and catecholaminergic innervation provide niche-level inhibitory signals [1, 4]. Additionally, developmental transcriptomic programs orchestrate the timing of proliferation decline. Environmental toxicants such as isoliquiritigenin can disrupt these regulatory networks.
negative regulation of cell proliferation in midbrain and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Ezh2 | Midbrain malformation, identity switch | Conditional knockout mouse |
| Gpr161 | Embryonic midbrain malformation, craniofacial defects | Wnt1 lineage-specific knockout mouse |
| Norepinephrine signaling | Altered adult neurogenesis | Pharmacological or genetic manipulation in mice |
| Isoliquiritigenin exposure | Neurodevelopmental toxicity | Zebrafish larvae |
| Cell cycle regulators | Abnormal midbrain size | Rat organogenesis model |
Midbrain malformations and craniofacial defects
Disruption of negative regulation of midbrain cell proliferation can lead to embryonic midbrain malformation and craniofacial skeletal defects. Wnt1 lineage-specific deletion of Gpr161 in mice results in such malformations, highlighting the importance of proper proliferation control. Loss of Ezh2 causes a midbrain-to-forebrain identity switch, which can have profound consequences for brain patterning.
Neurodevelopmental toxicity
Environmental toxicants can interfere with negative regulation of midbrain proliferation. Isoliquiritigenin induces neurodevelopmental toxicity and anxiety-like behavior in zebrafish larvae, likely by altering proliferation in the midbrain. This suggests that exposure to certain compounds may increase risk of neurodevelopmental disorders.
Neurodegeneration and adult neurogenesis
In the adult brain, negative regulation of proliferation in periventricular niches is critical for maintaining stem cell pools. Norepinephrine acts as a negative regulator of the adult periventricular neural stem cell niche. Catecholaminergic innervation of these regions in the developing brain further modulates neurogenesis. Dysregulation may contribute to impaired neurogenesis in neurodegenerative conditions.
From negative regulation of cell proliferation in midbrain-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate midbrain proliferation? | Conditional knockout mouse (e.g., Wnt1-Cre) |
| What is the effect of a point mutation in gene Y? | Knock-in mouse with point mutation |
| How does overexpression of gene Z affect midbrain size? | Transgenic overexpression mouse |
| Where and when is gene A expressed during midbrain development? | Tagged knock-in reporter mouse |
| What are the transcriptomic changes upon loss of gene B? | RNA-seq of microdissected midbrain |
| Can a drug modulate midbrain proliferation? | Zebrafish larvae toxicity assay |
How to Study the negative regulation of cell proliferation in midbrain Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify proliferation-regulating genes |
| ChIP-seq | Protein-DNA interactions | Map Ezh2 binding in midbrain |
| BrdU/Ki67 staining | Cell proliferation | Quantify midbrain proliferation |
| Lineage tracing | Cell fate | Track midbrain progenitors |
| Zebrafish toxicity assay | Neurodevelopmental effects | Test compounds like isoliquiritigenin |
| Single-cell RNA-seq | Cell-type-specific expression | Dissect midbrain heterogeneity |
| Western blot | Protein levels | Validate expression changes |
| Immunohistochemistry | Protein localization | Visualize midbrain markers |
Transcriptomic profiling
RNA sequencing of midbrain tissue at different developmental stages can reveal genes and pathways involved in negative regulation of proliferation. Temporal and spatial transcriptomic dynamics across brain development in Xenopus laevis tadpoles provide a framework for identifying proliferation-regulating genes.
Cell cycle analysis
Measuring cell cycle parameters (e.g., S-phase labeling, Ki67 staining) in the midbrain allows quantification of proliferation rates. Changes in cell cycle parameters and cell number in the rat midbrain during organogenesis have been documented using such methods.
Genetic lineage tracing
Lineage tracing using Cre-lox systems (e.g., Wnt1-Cre) can determine the fate of midbrain progenitors and how negative regulation affects their differentiation. This approach was used to show that Gpr161 deletion in the Wnt1 lineage causes midbrain malformation.
Epigenetic profiling
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for histone modifications and Ezh2 binding can identify direct targets that mediate negative regulation of proliferation in the midbrain.
How CRISPR Can Be Used to Study GO:1904934 negative regulation of cell proliferation in midbrain
Knockout
CRISPR knockout of candidate genes (e.g., Ezh2, Gpr161) in midbrain progenitor cells or animal models can test their role in negative regulation of proliferation. Conditional knockout using Wnt1-Cre and CRISPR-mediated gene deletion in mice has been used to study midbrain malformation.
Point Mutation
Introducing precise point mutations via CRISPR base editing or homology-directed repair can model human variants associated with midbrain disorders. For example, point mutations in Gpr161 might mimic patient alleles.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows visualization and tracking of midbrain progenitor cells. Tagged knock-in of Ezh2 can reveal its dynamic localization during proliferation arrest.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can drive candidate genes to test whether they are sufficient to inhibit midbrain proliferation. Overexpression of negative regulators like Ezh2 may reduce midbrain size.
How EDITGENE Supports negative regulation of cell proliferation in midbrain Research
Researchers studying negative regulation of cell proliferation in midbrain-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR-based services to accelerate such investigations, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cell proliferation in midbrain research.
Frequently Asked Questions About negative regulation of cell proliferation in midbrain
What is GO:1904934?
GO:1904934 is a Gene Ontology term for negative regulation of cell proliferation in midbrain, describing any process that stops, prevents, or reduces cell division in the midbrain.
What genes are involved in negative regulation of cell proliferation in midbrain?
Key genes include Ezh2, Wnt1, Gpr161, and components of catecholaminergic signaling [6, 8, 4].
How is midbrain cell proliferation negatively regulated?
It is regulated by epigenetic modifiers like Ezh2, signaling pathways such as Wnt, and niche factors like norepinephrine [6, 8, 1].
Why is negative regulation of midbrain proliferation important?
It ensures proper midbrain size and prevents malformations; dysregulation can cause neurodevelopmental defects [2, 8].
What diseases are linked to midbrain proliferation defects?
Embryonic midbrain malformation, craniofacial defects, and neurodevelopmental toxicity have been linked [8, 7].
What model organisms are used to study midbrain proliferation?
Mouse, rat, zebrafish, and Xenopus are commonly used [5, 7, 3].
How can CRISPR help study GO:1904934?
CRISPR knockout, point mutation, knock-in, and overexpression can test gene function in midbrain proliferation [6, 8].
What methods measure midbrain cell proliferation?
BrdU/Ki67 staining, cell cycle analysis, and RNA-seq are common [5, 3].
Is Ezh2 a negative regulator of midbrain proliferation?
Yes, loss of Ezh2 causes a midbrain-to-forebrain identity switch and deregulated proliferation.
What is the role of Gpr161 in midbrain development?
Gpr161 deletion in the Wnt1 lineage results in embryonic midbrain malformation and craniofacial defects.
Conclusion
GO:1904934, negative regulation of cell proliferation in midbrain, is a critical biological process that ensures proper midbrain development and function. Research has identified key regulators such as Ezh2, Wnt1, and Gpr161, and highlighted the consequences of their dysregulation in malformations and neurodevelopmental toxicity [6, 8, 7]. Continued investigation using CRISPR and advanced omics will further elucidate the mechanisms and therapeutic potential of targeting this process.
References
- 1. Weselek G et al.. 2020. Norepinephrine is a negative regulator of the adult periventricular neural stem cell niche.. Stem Cells 38(9):1188-1201 PMID: 32473039
- 2. Ishibashi M. 2004. Molecular mechanisms for morphogenesis of the central nervous system in mammals.. Anat Sci Int 79(4):226-34 PMID: 15633461
- 3. Ta AC et al.. 2022. Temporal and spatial transcriptomic dynamics across brain development in Xenopus laevis tadpoles.. G3 (Bethesda) 12(1) PMID: 34751375
- 4. Fauser M et al.. 2020. Catecholaminergic Innervation of Periventricular Neurogenic Regions of the Developing Mouse Brain.. Front Neuroanat 14:558435 PMID: 33071762
- 5. Lewandowski TA et al.. 2003. Changes in cell cycle parameters and cell number in the rat midbrain during organogenesis.. Brain Res Dev Brain Res 141(1-2):117-28 PMID: 12644255
- 6. Zemke M et al.. 2015. Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation.. BMC Biol 13:103 PMID: 26621269
- 7. Wang L et al.. 2023. Isoliquiritigenin induces neurodevelopmental-toxicity and anxiety-like behavior in zebrafish larvae.. Comp Biochem Physiol C Toxicol Pharmacol 266:109555 PMID: 36717046
- 8. Kim SE et al.. 2021. Wnt1 Lineage Specific Deletion of Gpr161 Results in Embryonic Midbrain Malformation and Failure of Craniofacial Skeletal Development.. Front Genet 12:761418 PMID: 34887903
